echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Natural Products News > The supreme leader spoke. The opportunity for traditional Chinese medicine is here

    The supreme leader spoke. The opportunity for traditional Chinese medicine is here

    • Last Update: 2019-06-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On the one hand, the state's encouragement of traditional Chinese medicine is the general direction of certainty On the other hand, some restrictive measures, such as the catalogue of auxiliary drugs, have been introduced There is a view in the industry that the future trend is to encourage the return of traditional Chinese medicine usage ▍ held a forum on traditional medicine to give full play to the advantages of traditional medicine recently, the top leaders of the state attended the 19th meeting of the Council of heads of state of SCO member states in Bishkek, Kyrgyzstan "China is willing to hold the SCO Forum on traditional medicine in due time, give full play to the advantages of traditional medicine, improve people's health and improve the level of medical and health care," he said in an important speech According to public information, traditional medicine refers to a variety of medical knowledge systems that have been independently developed before modern medicine, which is different from the mainstream system of modern medicine Traditional Chinese medicine is the general name of all ethnic medicine in China, mainly including Han (middle) medicine, Tibetan medicine, Mongolian medicine, Uygur Medicine and other ethnic medicine What deserves special attention is traditional Chinese medicine On May 25, 2019, the 72nd World Health Assembly in Geneva, Switzerland, reviewed and adopted the 11th revision of the international classification of diseases, including traditional medicine originated from traditional Chinese medicine for the first time It is understood that the international classification of diseases is an international unified disease classification standard formulated and promulgated by who It is a normative standard for disease classification of governments in medical treatment, management, teaching, scientific research and policy-making It is one of the authoritative basic and general standards in the field of global health Traditional medicine, which originated from traditional Chinese medicine, has been brought into the world health system This time, the top leaders proposed that the SCO Forum on traditional medicine should be held at the right time to give full play to the advantages of traditional medicine and to some extent promote the development of traditional medicine represented by traditional Chinese medicine ▍ to support the development of traditional Chinese medicine industry is a definite direction In fact, the state has always maintained its support for the development of traditional Chinese medicine industry In December 2016, the Information Office of the State Council issued the white paper of Chinese medicine, which shows that by 2020, everyone will basically enjoy the service of Chinese medicine, and it is expected that the large health industry of Chinese medicine will exceed 3 trillion yuan, and the industry scale is expected to maintain a compound growth rate of 20% In August 2016, the State Administration of traditional Chinese Medicine issued the 13th five year plan for the development of traditional Chinese medicine, which is expected to double the scale of traditional Chinese medicine industry in 2020 In 2016, the total output value of traditional Chinese medicine industry reached 786.7 billion yuan It is estimated that by 2020, the main business income of Enterprises above the scale of traditional Chinese medicine industry will exceed 1.5 trillion yuan, and the total number of TCM doctors and therapists is expected to reach 1.3 billion yuan, which is more obvious in the medical insurance catalog According to Chapter 7 and Article 49 of the law on traditional Chinese medicine, the relevant departments of the local people's governments at or above the county level shall include the eligible traditional Chinese medicine and traditional Chinese medicine preparations of medical institutions into the payment scope of the basic medical insurance fund The performance of the data is more intuitive: in the medical insurance catalogue of version 05, version 09 and version 17, the number of traditional Chinese medicine increased from 870 (including 47 ethnic medicine) to 1237 (including 88 ethnic medicine), and the proportion of traditional Chinese medicine increased from 45.9% to 48.9% ▍ on the one hand, the State encourages the return of traditional Chinese medicine usage On the other hand, it has introduced some restrictive measures such as the catalogue of auxiliary drugs Especially in the current background of medical insurance and fee control, many medical institutions begin to "knife" traditional Chinese medicine, many of which are limited in admission, clinical use and drug proportion According to the public data of iqvia aikunwei consulting, the traditional Chinese medicine prescription value of medical institutions above level 2 decreased by 7% in 2017, while that of imported and foreign-funded enterprises increased by 9% in the same period; according to the data of Zhongkang information, the proportion of traditional Chinese medicine in grade 2 hospitals (above level 2) decreased from 19.1% in 2014 to 16.8% in 2018; according to the data of the Ministry of industry and information technology, in 2017 and 2018, the proportion of traditional Chinese medicine owners decreased The cumulative decline of business income was as high as 37.7% The proportion of main business income of Chinese patent medicine industry in the pharmaceutical industry also declined year by year, from 23.63% in 2013 to 19.23% in 2017 In addition, due to the impact of increased cost control, the revenue of large varieties of traditional Chinese medicine injections of many enterprises has declined significantly, which has slowed down the performance growth of the whole industry In this regard, there is a view in the industry that the future trend is to encourage the return of traditional Chinese medicine usage The encouraging oral varieties mainly come from the change of restrictions on traditional Chinese medicine injections set by the new version of the medical insurance catalogue Under the joint influence of zero addition, drug proportion and the new version of the medical insurance catalogue, traditional Chinese medicine pieces also ushered in a turning point of growth The market scale increased from 24.2 billion yuan in 2007 to nearly 200 billion yuan in 2016, with an average annual growth rate of 26%, leading the pharmaceutical industry In addition, OTC of traditional Chinese medicine and brand traditional Chinese medicine are also areas worthy of attention, and still maintain rapid growth  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.